Asthma Trials in Białystok, Poland
Conditions / Asthma / Białystok, Poland
Asthma has been the subject of sustained clinical investigation across multiple research sites.
106 total trials for this combination
Showing top 10 of 106 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06052267 | A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations | RECRUITING | PHASE3 |
| NCT01928771 | Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma | COMPLETED | PHASE3 |
| NCT06676319 | Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma | RECRUITING | — |
| NCT02258542 | A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA | COMPLETED | PHASE3 |
| NCT01462344 | 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old | COMPLETED | PHASE4 |
| NCT02414854 | Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) | COMPLETED | PHASE3 |
| NCT02134028 | Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) | COMPLETED | PHASE3 |
| NCT00332826 | Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma | TERMINATED | PHASE3 |
| NCT02924688 | A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma | COMPLETED | PHASE3 |
| NCT01576718 | A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications | COMPLETED | PHASE2 |